However, reports that COUP-TFI both activates and inhibits estrogen signaling in breast cancer cells [65,66] suggests that applications of compounds such as DIM-C-Pyr4 for treating breast and other cancer requires further investigation. The gene discussed is NR2F1; the disease is breast carcinoma.